Pulmonx Corporation LUNG Proceeds from Maturities, Prepayments and Calls of Short-Term Investments
Proceeds from Maturities, Prepayments and Calls of Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Pulmonx Corporation in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments.
The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulmonx Corporation's proceeds from maturities, prepayments and calls of short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulmonx Corporation's proceeds from maturities, prepayments and calls of short-term investments?
- Pulmonx Corporation (LUNG) reported proceeds from maturities, prepayments and calls of short-term investments of $0 in Q1 2026.
- How has Pulmonx Corporation's proceeds from maturities, prepayments and calls of short-term investments changed year-over-year?
- Pulmonx Corporation's proceeds from maturities, prepayments and calls of short-term investments decreased by 100.0% year-over-year, from $20.54M to $0.
- What is the long-term trend for Pulmonx Corporation's proceeds from maturities, prepayments and calls of short-term investments?
- Over 4 years (2021 to 2025), Pulmonx Corporation's proceeds from maturities, prepayments and calls of short-term investments has grown at a 38.3% compound annual growth rate (CAGR), from $10M to $36.59M.